Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report
Abstract Background Identifying the most appropriate antiretroviral regimen for pregnant women with Human Immunodeficiency Virus (HIV-1) infection can be challenging, mainly due to pregnancy-related physiological alterations which can significantly reduce maternal drug plasma concentration. We would...
Main Authors: | Sheila Chiesi, Sebastiano Rizzardo, Daniela Piacentini, Giorgia Be, Emanuela Lattuada, Evelina Tacconelli, Massimiliano Lanzafame |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-019-2148-y |
Similar Items
-
Evaluation of the Side Effects of Antiretroviral Treatment
by: Sedef BAŞGÖNÜL, et al.
Published: (2018-12-01) -
The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study
by: Calcagno, A., et al.
Published: (2022) -
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data
by: Amedeo F. Capetti, et al.
Published: (2017-09-01) -
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance
by: Eva Wolf, et al.
Published: (2021-09-01) -
The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
by: Mehta R, et al.
Published: (2020-06-01)